Jonathan Will McGuire is Director at SECOND SIGHT MEDICAL PRODUCTS INC (EYES). They have made 9 open-market trades across 2 companies since 2018, most recently 2022-11-20.
CIK 0001345539
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $8K since 2020, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RMED | SELL | 2021-11-22 | 2021-11-24 | $2.62 | $21K | -26.0% | -32.8% | -85.7% |
| RMED | BUY | 2020-08-03 | 2020-08-05 | $0.35 | $4K | +3.3% | -6.4% | -36.3% |
| RMED | BUY | 2020-05-22 | 2020-05-27 | $0.46 | $5K | +17.6% | -6.3% | -30.4% |
| EYES | SELL | 2020-02-20 | 2020-02-21 | $5.44 | $10K | -25.7% | -61.4% | -83.2% |
| EYES | SELL | 2019-08-20 | 2019-08-20 | $0.81 | $3K | +0.6% | +19.4% | +10.8% |
| EYES | SELL | 2019-05-21 | 2019-05-22 | $0.85 | $3K | -16.6% | -9.4% | -9.4% |
| EYES | SELL | 2019-02-20 | 2019-02-21 | $0.73 | $3K | +2.8% | +3.5% | +8.8% |
| EYES | SELL | 2018-11-21 | 2018-11-21 | $1.16 | $5K | -16.2% | -36.7% | -38.3% |
| EYES | SELL · 10b5-1 | 2018-10-01 | 2018-10-02 | $1.87 | $19K | -6.9% | -6.3% | -49.4% |
| EYES | SELL · 10b5-1 | 2018-09-04 | 2018-09-06 | $1.68 | $17K | +1.1% | -8.6% | -45.1% |
| EYES | SELL · Routine | 2018-08-21 | 2018-08-22 | $1.60 | $6K | +7.4% | +14.7% | -27.6% |
| EYES | SELL | 2018-05-21 | 2018-05-22 | $2.18 | $8K | -11.5% | -20.3% | -27.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.